跳至主要内容
临床试验/NCT01191242
NCT01191242已完成不适用

Methadone Monitoring for Insights Into Adverse Events

Intermountain Health Care, Inc.2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
2
主要终点
Total Methadone Peak Plasma Concentration

研究概览

简要总结

Methadone has been an effective and inexpensive therapy in the management of chronic pain and opioid dependence. However it has been associated with sudden, unexpected deaths. Two mechanisms have been suggested, increased drug concentration in the blood, and a change in the heart rhythm. This study will look at blood samples for drug levels and genetic components and EKG's (a noninvasive test which reveals heart rhythm). There will be no intervention.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • must be 18 years of age or older; eligible for methadone treatment as judged by Discovery House criteria
  • must sign informed consent for methadone treatment prior to being approached for this study
  • must sign a written informed consent for this study
  • is willing and has a means to return for all scheduled follow-up visits

排除标准

  • pregnancy, participation in any other clinical trial involving investigational or marketed products with 30 days prior to entry into this study; current use of an inducer/inhibitor of known enzymes involved with methadone metabolism
  • use of methadone in the 30 days prior to study enrollment; concomitant use of QT prolonging drugs
  • considered by the treatment physician to be ineligible for methadone treatment; hepatic function panel indicates chronic liver disease.

结局指标

主要结局

Total Methadone Peak Plasma Concentration

时间窗: Day 1, Day 7, Day 21

(S)- Methadone Peak Plasma Concentration

时间窗: Day 1, Day 7, Day 21

(R)-Methadone Peak Plasma Concentration

时间窗: Day 1, Day 7, Day 21

(R)-Methadone Trough Plasma Concentration

时间窗: Day 1, Day 7, Day 21

(S)-EDDP Peak Plasma Concentration

时间窗: Day 1, Day 7, Day 21

(R)-EDDP Peak Plasma Concentration

时间窗: Day 1, Day 7, Day 21

Total Methadone Trough Plasma Concentration

时间窗: Day 1, Day 7, Day 21

(R)-EDDP Trough Plasma Concentration

时间窗: Day 1, Day 7, Day 21

(S)- Methadone Trough Plasma Concentration

时间窗: Day 1, Day 7, Day 21

Total 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidene (EDDP) Peak Plasma Concentration

时间窗: Day 1, Day 7, Day 21

Total EDDP Trough Plasma Concentration

时间窗: Day 1, Day 7, Day 21

(S)-EDDP Trough Plasma Concentration

时间窗: Day 1, Day 7, Day 21

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验